SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Drugs fixes record date for interim dividend

07 Feb 2020 Evaluate

Aarti Drugs has informed that the Board of Directors of the Company at its Meeting held on Thursday, February 6, 2020, has declared the Interim Dividend at the rate of Rs 2 (20%) per Equity share for the financial year 2019-20. As per Regulation 42(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed February 18, 2020 as the Record Date for the purpose of Payment of Interim Dividend.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs Share Price

396.50 8.95 (2.31%)
09-Jul-2026 11:07 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1926.10
Dr. Reddys Labs. 1278.85
Cipla 1440.10
Zydus Lifesciences 1164.40
Lupin 2500.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: